Ameritas Investment Partners, Inc. Sera Prognostics, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 2,704 shares of SERA stock, worth $11,032. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,704
Previous 2,704
-0.0%
Holding current value
$11,032
Previous $21,000
9.52%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SERA
# of Institutions
77Shares Held
20.4MCall Options Held
28.9KPut Options Held
36.8K-
Baker Bros. Advisors LP New York, NY5.43MShares$22.2 Million0.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$12.4 Million0.43% of portfolio
-
Interwest Venture Management CO2.42MShares$9.86 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$6.73 Million2.79% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$5.75 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $121M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...